Consistently, we observed a simultaneous increase of apoptotic (cleaved-caspase3) and mitotic (PLK1 and FOXM1) markers at 24 h post RGS treatment in melanoma cells (Fig. 1 c &Suppl.Fig. 1). The gene discussed is PLK1; the disease is melanoma.